Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Letrozole”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07340658
What this trial is testing

Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Advanced, Metastatic Breast Cancer
Rovi Pharmaceuticals Laboratories 300
Not applicableStudy completedNCT06413771
What this trial is testing

Only Gonadotropin Vs. Letrozole Combined Gonadotropin Stimulation in IUI Cycles

Who this might be right for
Infertility Unexplained
Uludag University 131
Not applicableLooking for participantsNCT06041204
What this trial is testing

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Who this might be right for
PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesSubclinical HypothyroidismFemale Infertility
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy 200
Post-approval studies (Phase 4)UnknownNCT04217265
What this trial is testing

Letrozole Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion

Who this might be right for
Missed Abortion
Cairo University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04568616
What this trial is testing

Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)

Who this might be right for
Breast CancerER Positive Breast Cancer
Dartmouth-Hitchcock Medical Center 178
Post-approval studies (Phase 4)Ended earlyNCT05183828
What this trial is testing

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Washington 62
Testing effectiveness (Phase 2)Study completedNCT02730429
What this trial is testing

Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 78
Not applicableNot Yet RecruitingNCT06733727
What this trial is testing

Letrozole Versus Mifepristone and Misoprostol in Silent Miscarriage

Who this might be right for
Silent Miscarriage
The University of Hong Kong 884
Testing effectiveness (Phase 2)Study completedNCT00066339
What this trial is testing

Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Testing effectiveness (Phase 2)UnknownNCT04194658
What this trial is testing

Effectiveness of Pretreatment Letrozole Versus Misoprostol Alone in Missed Abortion

Who this might be right for
Medical; Abortion, Fetus
Cairo University 150
Testing effectiveness (Phase 2)Ended earlyNCT01430585
What this trial is testing

Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

Who this might be right for
Early Breast Cancer (Phase 2)Advanced Breast Cancer (Phase 1b)
Pfizer 14
Testing effectiveness (Phase 2)Ended earlyNCT00414076
What this trial is testing

Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma

Who this might be right for
LeiomyosarcomaUterine Neoplasm
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Ended earlyNCT02115048
What this trial is testing

Clinical Study for the Treatment of Breast Cancer: the Patient Will Receive Afatinib Plus Letrozole or Letrozole Alone

Who this might be right for
Breast Neoplasms
Translational Research in Oncology 44
Testing effectiveness (Phase 2)Ended earlyNCT03709082
What this trial is testing

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerBreast Cancer Metastatic
University of Kansas Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT00617968
What this trial is testing

GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer

Who this might be right for
Breast Neoplasms
Sanofi 5
Not applicableStudy completedNCT02158689
What this trial is testing

Comparison of Treatment Modalities in Poor Responders Undergoing IVF

Who this might be right for
Poor Responders
Ercan Bastu 80
Large-scale testing (Phase 3)UnknownNCT03664050
What this trial is testing

Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary

Who this might be right for
Induction of Ovulation
Ain Shams University 90
Not applicableStudy completedNCT06426979
What this trial is testing

Sequential Letrozole and Methotrexate Therapy Role in Treatment of Tubal Ectopic Pregnancy

Who this might be right for
Pregnancy Tubal
Zagazig University 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07305246
What this trial is testing

Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

Who this might be right for
Breast Cancer
First Hospital of China Medical University 120
Testing effectiveness (Phase 2)Study completedNCT00050141
What this trial is testing

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

Who this might be right for
Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 121
Next Page